Frazier Life Sciences Public Fund, L.P.

Holdings History for KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Symbol: KALV on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 3,466,521 shares
Security Ownership %: 6.9%

Frazier Life Sciences Public Fund, L.P. ownership in KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV)

04 Nov 2025 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,466,521 shares of KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV). This represents 6.9% ownership of the company. In their previous filing dated 20 Aug 2025, Frazier Life Sciences Public Fund, L.P. had reported owning 2,400,276 shares, indicating an increase of +44%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Frazier Life Sciences Public Fund, L.P.	6.9%	+42%	$42,222,226	3,466,521	+1,066,245	+44%	$12.18	13D/A	01 Nov 2025	04 Nov 2025, 17:21
Frazier Life Sciences Public Fund, L.P.	4.8%		$37,348,295	2,400,276			$15.56	13D/A	18 Aug 2025	20 Aug 2025, 17:20